Marzena Michalak-Kloc

Protocol for a multicenter, double-blind, randomized, placebo-controlled phase III trial of the inhaled β2-adrenergic receptor agonist salbutamol for transient tachypnea of the newborn (the REFSAL trial)

H. Sławska, T. Daboval, R. Bokiniec, 2023, Frontiers in Pediatrics.